Carpal Tunnel Syndrome (CTS) Post-burnNCT07660328

Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome

A study testing Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR } and Standard Hand Rehabilitation [ US } in people with Carpal Tunnel Syndrome (CTS) Post-burn, run by Cairo University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts

Official record

Search all trials

Trial summary

Who is it for?: Ages 20 to 40 years
Conditions the study is for: Carpal Tunnel Syndrome (CTS) Post-burn
What is being tested?: Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR } and Standard Hand Rehabilitation [ US }
Type of treatment: Medical device
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 52 participants
Where: 1 siteEgypt
Study dates: 9 Aug 2026to 1 Dec 2026
Phase: Interventional
Are there results?: Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 20 to 40 years
All sexes
No healthy volunteers
Adult

Who may be able to join

Participant is between 20 and 40 years of age.
Diagnosed with mild to moderate carpal tunnel syndrome (CTS).
History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%.
Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome.
Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test.
Participant provides written informed consent before enrollment.

Who cannot join

History of double crush syndrome, cervical radiculopathy, or fibromyalgia.
History of wrist fracture or distal radius fracture.
Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA).
Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases.
Current or past history of cancer.
Use of a hand or wrist splint within the past three months.
Presence of an implanted pacemaker or electrical prosthesis.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ahmed abdelnasr Mohamed Youness, Demonstrator (TA) contact

+2001553712231

pt.ahmed.mido@gmail.com

Nada Mohamed Yousef, Lecturer contact

+2001002010168

Dr.nada123.ny@gmail.com

Egypt1 site, 1 recruiting

QWAM physio clinic
Al Mansurah, Mansoura, 35511
Mohamed Mohamed Abdelwahab, Supervisor, +2001557393444, outlast829@gmail.com
Recruiting

Other trials in Egypt

About this study

Official title: Effect of Transfer Energy Capacitive and Resistive on Carpal Tunnel Syndrome Post Burn

Carpal Tunnel Syndrome (CTS) is a common entrapment neuropathy that can develop as a secondary complication following deep burns involving the hand or wrist. Post-burn CTS arises due to factors such as fibrosis, edema, and scar contracture, which may increase pressure on the median nerve within the carpal tunnel, leading to significant pain, sensory disturbances, and impaired hand function Recent studies support the effectiveness of Transfer Energy Capacitive and Resistive (TECAR ) therapy in idiopathic CTS, showing improvements in pain, symptom severity, and function, as measured by validated tools such as the Boston Carpal Tunnel Questionnaire (BCTQ) and Visual Analogue Scale (VAS).

A study reported that both TECAR and ultrasound groups showed significant symptom improvement after treatment, although ultrasound had more sustained effects on median nerve cross-sectional area at 3 months

Read the detailed description

This study will involve 52 patients diagnosed with CTS post-burn; they will receive TECAR as an intervention. The outcome measures include ( VAS, Arabic version of Boston Carpal Tunnel Questionnaire, and Camry Digital Handgrip Dynamometer

Conditions: Carpal Tunnel Syndrome (CTS) Post-burn
Being tested: Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }, Standard Hand Rehabilitation [ US }
Keywords: carpal tunnel syndrome post-burn, TECAR, Hand grip, BOSTON questionnaire, VAS
Medical subject headings: Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }Device
TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), The passive electrode was fixed to the dorsum of the hand while the active electrode was moved in a circular manner from the proximal carpal tunnel to the median nerve pathway of the palm in three sessions per week for two weeks
Standard Hand Rehabilitation [ US }Other
US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises

Study groups in NCT07660328
Study group	Role	What they receive
The TECAR Group	Experimental	Participants in this group will receive TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), three sessions per week for two weeks plus standard post-burn hand rehabilitation Receives: Device: Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }; Other: Standard Hand Rehabilitation [ US }
The Control Group	Active comparator	Participants in this arm will receive standard post-burn hand rehabilitation (e.g., Exercise, stretch, and US) Receives: Other: Standard Hand Rehabilitation [ US }

What is being measured

The primary outcome is the main question the study is designed to answer.

Symptom Severity
The Arabic version of the BCTQ-SSS will be used to self-report symptom severity. It consists of 11 items assessing pain, numbness, paresthesia, weakness, and nocturnal symptoms. Each item is scored from 1 (never/none) to 5 (most severe). The overall score is calculated as the mean of the items, ranging from 1 to 5, where higher scores indicate worse symptom severity.
Measured: Baseline and 2 weeks
Functional Status
The Arabic version of the BCTQ-FSS will be used to evaluate hand function across 8 common activities. Each activity is scored from 1 (no difficulty) to 5 (cannot perform the activity at all). The total score is the mean of the items, ranging from 1 to 5, where higher scores represent greater functional impairment.
Measured: Baseline and 2 weeks.
Grip Strength
Objective hand function and force production of the median nerve-innervated muscles will be measured using a Camry Digital Handgrip Dynamometer. Measurements are recorded in kilograms (kg), up to a maximum strength of 90 kg. Higher scores indicate greater hand grip strength.
Measured: Baseline and 2 weeks.

Secondary outcomes (1)

Pain Intensity
Pain intensity will be measured using the Arabic version of the VAS, where patients mark their current pain level on a 10-cm line. The scale ranges from 0 cm ("no pain") to 10 cm ("worst pain"). Higher scores represent greater pain severity.
Measured: Baseline and 2 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

9 Aug 20261 Dec 2026

First posted22 Jun 2026
Study start9 Aug 2026
Primary completion30 Oct 2026 (estimated)
Study completion1 Dec 2026 (estimated)

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Publications (18)Papers the sponsor has linked to this study.
Other trials for Carpal Tunnel Syndrome (CTS) Post-burnStudies of the same condition, open and under way.
More trials run by Cairo UniversityThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: Single blind
Who is masked: Investigator
Enrolment: 52 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07660328
Sponsor's protocol ID: TECAR on post burn CTS
Status last verified: Oct 2026
First submitted: 16 Jun 2026
Last updated: 28 Oct 2026
Results posted: No
Data monitoring committee: Yes
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Publications

Yeste-Fabregat M, Baraja-Vegas L, Vicente-Mampel J, Perez-Bermejo M, Bautista Gonzalez IJ, Barrios C. Acute Effects of Tecar Therapy on Skin Temperature, Ankle Mobility and Hyperalgesia in Myofascial Pain Syndrome in Professional Basketball Players: A Pilot Study. Int J Environ Res Public Health. 2021 Aug 19;18(16):8756. doi: 10.3390/ijerph18168756.
PubMed 34444508
Vahdatpour, B., Ghasemi, H. R., & Taheri, P. (2023). Effectiveness of TECAR Therapy on Clinical Symptoms and Neurophysiological Parameters of Patients with Carpal Tunnel Syndrome: A Randomized Clinical Trial. Middle East Journal of Rehabilitation and Health Studies, 10(3). https://doi.org/10.5812/mejrh-134171
Tezen O, Bilir EE, Uzun O, Yaniktas D, Senturk B, Yasar E. Evaluation of the efficacy of transfer energy capacitive and resistive therapy in patients with knee osteoarthritis. Turk J Med Sci. 2024 Oct 7;54(6):1302-1309. doi: 10.55730/1300-0144.5913. eCollection 2024.
PubMed 39734340
Tashiro Y, Hasegawa S, Yokota Y, Nishiguchi S, Fukutani N, Shirooka H, Tasaka S, Matsushita T, Matsubara K, Nakayama Y, Sonoda T, Tsuboyama T, Aoyama T. Effect of Capacitive and Resistive electric transfer on haemoglobin saturation and tissue temperature. Int J Hyperthermia. 2017 Sep;33(6):696-702. doi: 10.1080/02656736.2017.1289252. Epub 2017 Feb 19.
PubMed 28139939
Tezen O, Ata AM, Uzun O, Cakir F, Yasar E. Comparison of the effectiveness of ultrasound and transfer energy capacitive and resistive (TECAR) therapy in patients with carpal tunnel syndrome. Lasers Med Sci. 2025 Mar 19;40(1):147. doi: 10.1007/s10103-025-04412-z.
PubMed 40106005
Szabo DA, Neagu N, Teodorescu S, Predescu C, Sopa IS, Panait L. TECAR Therapy Associated with High-Intensity Laser Therapy (Hilt) and Manual Therapy in the Treatment of Muscle Disorders: A Literature Review on the Theorised Effects Supporting Their Use. J Clin Med. 2022 Oct 19;11(20):6149. doi: 10.3390/jcm11206149.
PubMed 36294470
Rosario NB, De Jesus O. Electrodiagnostic Evaluation of Carpal Tunnel Syndrome. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562235/
PubMed 32965906
Ribeiro, S., Henriques, B., & Cardoso, R. (2018). To cite this article Samuel Ribeiro, Bebiana Henriques, Ricardo Cardoso. The Effectiveness of Tecar Therapy in Musculoskeletal Disorders. In International Journal of Public Health and Health Systems (Vol. 3, Issue 5). http://www.openscienceonline.com/journal/ijphhs
Niajalili M, Mohsen Roostayi M, Daryabor A, Naimi SS, Amoli MJ. The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. Turk J Phys Med Rehabil. 2023 Oct 12;69(4):479-487. doi: 10.5606/tftrd.2023.11875. eCollection 2023 Dec.
PubMed 38766579
Mitie Ida, A., Borba Neves, E., & Wan Stadnik, A. M. (2023). Effects of Tecartherapy on Body Tissue: A Systematic Review. Journal of Biomedical Science and Engineering, 16(10), 133-148. https://doi.org/10.4236/jbise.2023.1610010
Mahran, H. G., Mohammed, A. H., & Aboelazm, S. N. (2015). EXTRACORPOREAL SHOCKWAVE THERAPY FOR POST BURN CARPAL TUNNEL SYNDROME. International Journal of Physiotherapy and Research, 3(2), 938-946. https://doi.org/10.16965/ijpr.2015.111
Lupton-Smith A, Fourie K, Mazinyo A, Mokone M, Nxaba S, Morrow B. Measurement of hand grip strength: A cross-sectional study of two dynamometry devices. S Afr J Physiother. 2022 Sep 26;78(1):1768. doi: 10.4102/sajp.v78i1.1768. eCollection 2022.
PubMed 36262213
Lupowitz LG, Ramus L, Delacour F, Johnson K. TECAR Therapy: A Clinical Commentary on its Evolution, Application, and Future in Rehabilitation. Int J Sports Phys Ther. 2025 Apr 1;20(4):632-640. doi: 10.26603/001c.130909. eCollection 2025.
PubMed 40182911
Diagne, N., Tonga, M., Seye, M., Sy, A., Mboup, D., Guèye, A., Sakho, M., Lo, P., Seck, L., Fall, M., Ndiaye, M., & Diop, A. (2024). Grip Strength and Carpal Tunnel: What Interest in Management. Journal of Physical Medicine, 5(1). https://doi.org/10.36959/942/347
Chesterton LS, Blagojevic-Bucknall M, Burton C, Dziedzic KS, Davenport G, Jowett SM, Myers HL, Oppong R, Rathod-Mistry T, van der Windt DA, Hay EM, Roddy E. The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial. Lancet. 2018 Oct 20;392(10156):1423-1433. doi: 10.1016/S0140-6736(18)31572-1.
PubMed 30343858

Study at a glance

From the registry record, last updated by the sponsor on 28 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Effect of Transfer Energy Capacitive and Resistive on Carpal Tunnel Syndrome Post Burn
ClinicalTrials.gov ID: NCT07660328
Acronym / sponsor ID: TECAR on post burn CTS
Conditions: Carpal Tunnel Syndrome (CTS) Post-burn
Keywords: carpal tunnel syndrome post-burn, TECAR, Hand grip, BOSTON questionnaire, VAS
Study type: Interventional
Recruitment status: Recruiting
Enrolment: 52 participants (estimated)
Lead sponsor: Cairo UniversityUniversity, hospital or other
Study start: 9 Aug 2026 (actual)
Primary completion: 30 Oct 2026 (estimated)
Study completion: 1 Dec 2026 (estimated)
First posted: 22 Jun 2026 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Detailed description

Study design

Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: Single blind (investigator)
Number of arms: 2

Arm	Type	Receives
The TECAR Group	Experimental	Device: Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }, Other: Standard Hand Rehabilitation [ US }Participants in this group will receive TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), three sessions per week for two weeks plus standard post-burn hand rehabilitation
The Control Group	Active comparator	Other: Standard Hand Rehabilitation [ US }Participants in this arm will receive standard post-burn hand rehabilitation (e.g., Exercise, stretch, and US)

Who may qualify

Ages: 20 to 40 years
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult

Key inclusion criteria (6 listed)

Participant is between 20 and 40 years of age.
Diagnosed with mild to moderate carpal tunnel syndrome (CTS).
History of an upper limb burn, with the percentage of the Total Body Surface Area (TBSA) ranging from 20% to 25%.
Upper limb burn is diagnosed as a 2nd or 3rd-degree burn complicated with carpal tunnel syndrome.
Carpal tunnel syndrome diagnosis is clinically confirmed using physical examination, including a positive Tinel's sign and positive Phalen's test.

Key exclusion criteria (7 listed)

History of double crush syndrome, cervical radiculopathy, or fibromyalgia.
History of wrist fracture or distal radius fracture.
Diagnosis of systemic or local diseases that contribute to peripheral neuropathy, including Diabetes Mellitus or rheumatoid arthritis (RA).
Diagnosis of hypothyroidism, skin diseases, or peripheral vascular diseases.
Current or past history of cancer.

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Transfer Energy Capacitive and Resistive (TECAR) [ SMART TECAR }TECAR therapy at a frequency of 0.5 MHz and intensity of 30 to 50% and medium Capacitive Energy Transfer electrode (60 mm), 5 min capacitive (CAP) and 10 min resistive (RES), The passive electrode was fixed to the dorsum of the hand while the active electrode was moved in a circular manner from the proximal carpal tunnel to the median nerve pathway of the palm in three sessions per week for two weeks	Device	The TECAR Group
Standard Hand Rehabilitation [ US }US using a 3 MHz probe at a dose of 1.5 watts/cm2 for 5 min intermittently for 2 weeks, 5 times a week, plus mobility and strengthening exercises	Other	The Control Group, The TECAR Group

Primary outcome

Symptom Severity
Time frame: Baseline and 2 weeks
The Arabic version of the BCTQ-SSS will be used to self-report symptom severity. It consists of 11 items assessing pain, numbness, paresthesia, weakness, and nocturnal symptoms. Each item is scored from 1 (never/none) to 5 (most severe). The overall score is calculated as the mean of the items, ranging from 1 to 5, where higher scores indicate worse symptom severity.
Functional Status
Time frame: Baseline and 2 weeks.
The Arabic version of the BCTQ-FSS will be used to evaluate hand function across 8 common activities. Each activity is scored from 1 (no difficulty) to 5 (cannot perform the activity at all). The total score is the mean of the items, ranging from 1 to 5, where higher scores represent greater functional impairment.
Grip Strength
Time frame: Baseline and 2 weeks.
Objective hand function and force production of the median nerve-innervated muscles will be measured using a Camry Digital Handgrip Dynamometer. Measurements are recorded in kilograms (kg), up to a maximum strength of 90 kg. Higher scores indicate greater hand grip strength.

1 secondary outcome

Pain Intensity
Time frame: Baseline and 2 weeks.

Results and safety

This study is still under way. Results are not available in the source record yet.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2026.
Background: PubMed 34444508Yeste-Fabregat M, Baraja-Vegas L, Vicente-Mampel J, Perez-Bermejo M, Bautista Gonzalez IJ, Barrios C. Acute Effects of Tecar Therapy on Skin Temperature, Ankle Mobility and Hyperalgesia in Myofascial Pain Syndrome in Professional Basketball Players: A Pilot Study. Int J Environ Res Public Health. 2021 Aug 19;18(16):8756. doi: 10.3390/ijerph18168756.
BackgroundVahdatpour, B., Ghasemi, H. R., & Taheri, P. (2023). Effectiveness of TECAR Therapy on Clinical Symptoms and Neurophysiological Parameters of Patients with Carpal Tunnel Syndrome: A Randomized Clinical Trial. Middle East Journal of Rehabilitation and Health Studies, 10(3). https://doi.org/10.5812/mejrh-134171
Background: PubMed 39734340Tezen O, Bilir EE, Uzun O, Yaniktas D, Senturk B, Yasar E. Evaluation of the efficacy of transfer energy capacitive and resistive therapy in patients with knee osteoarthritis. Turk J Med Sci. 2024 Oct 7;54(6):1302-1309. doi: 10.55730/1300-0144.5913. eCollection 2024.
Background: PubMed 28139939Tashiro Y, Hasegawa S, Yokota Y, Nishiguchi S, Fukutani N, Shirooka H, Tasaka S, Matsushita T, Matsubara K, Nakayama Y, Sonoda T, Tsuboyama T, Aoyama T. Effect of Capacitive and Resistive electric transfer on haemoglobin saturation and tissue temperature. Int J Hyperthermia. 2017 Sep;33(6):696-702. doi: 10.1080/02656736.2017.1289252. Epub 2017 Feb 19.
Background: PubMed 40106005Tezen O, Ata AM, Uzun O, Cakir F, Yasar E. Comparison of the effectiveness of ultrasound and transfer energy capacitive and resistive (TECAR) therapy in patients with carpal tunnel syndrome. Lasers Med Sci. 2025 Mar 19;40(1):147. doi: 10.1007/s10103-025-04412-z.
Background: PubMed 36294470Szabo DA, Neagu N, Teodorescu S, Predescu C, Sopa IS, Panait L. TECAR Therapy Associated with High-Intensity Laser Therapy (Hilt) and Manual Therapy in the Treatment of Muscle Disorders: A Literature Review on the Theorised Effects Supporting Their Use. J Clin Med. 2022 Oct 19;11(20):6149. doi: 10.3390/jcm11206149.
Background: PubMed 32965906Rosario NB, De Jesus O. Electrodiagnostic Evaluation of Carpal Tunnel Syndrome. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK562235/
BackgroundRibeiro, S., Henriques, B., & Cardoso, R. (2018). To cite this article Samuel Ribeiro, Bebiana Henriques, Ricardo Cardoso. The Effectiveness of Tecar Therapy in Musculoskeletal Disorders. In International Journal of Public Health and Health Systems (Vol. 3, Issue 5). http://www.openscienceonline.com/journal/ijphhs
Background: PubMed 38766579Niajalili M, Mohsen Roostayi M, Daryabor A, Naimi SS, Amoli MJ. The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study. Turk J Phys Med Rehabil. 2023 Oct 12;69(4):479-487. doi: 10.5606/tftrd.2023.11875. eCollection 2023 Dec.
BackgroundMitie Ida, A., Borba Neves, E., & Wan Stadnik, A. M. (2023). Effects of Tecartherapy on Body Tissue: A Systematic Review. Journal of Biomedical Science and Engineering, 16(10), 133-148. https://doi.org/10.4236/jbise.2023.1610010
BackgroundMahran, H. G., Mohammed, A. H., & Aboelazm, S. N. (2015). EXTRACORPOREAL SHOCKWAVE THERAPY FOR POST BURN CARPAL TUNNEL SYNDROME. International Journal of Physiotherapy and Research, 3(2), 938-946. https://doi.org/10.16965/ijpr.2015.111
Background: PubMed 36262213Lupton-Smith A, Fourie K, Mazinyo A, Mokone M, Nxaba S, Morrow B. Measurement of hand grip strength: A cross-sectional study of two dynamometry devices. S Afr J Physiother. 2022 Sep 26;78(1):1768. doi: 10.4102/sajp.v78i1.1768. eCollection 2022.
Individual participant dataSharing planned: No

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.

Ahmed abdelnasr Mohamed Youness, Demonstrator (TA) contact

+2001553712231

pt.ahmed.mido@gmail.com

Nada Mohamed Yousef, Lecturer contact

+2001002010168

Dr.nada123.ny@gmail.com

Wafaa Hussien Borhan, Professor study director

Cairo University

Ashraf Alsibai Mohamed, Professor study director

Cairo University

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ahmed abdelnasr Mohamed Youness, Demonstrator (TA) (+2001553712231, pt.ahmed.mido@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptom Severity (time frame: Baseline and 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07660328, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.